Clinical operations and pharmacovigilance are often managed in parallel — but in early-phase and complex trials, that separation can create avoidable risk. Delayed safety decisions, protocol amendments, inconsistent safety data handling, and added pressure on sites can directly affect both patient safety and development timelines. In this on-demand webinar, experts from Ergomed Clinical Research and … Continued